Parkwood LLC reduced its holdings in shares of Danaher Co. (NYSE:DHR – Get Rating) by 0.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,467 shares of the conglomerate’s stock after selling 132 shares during the period. Parkwood LLC’s holdings in Danaher were worth $6,405,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also recently bought and sold shares of DHR. Camden National Bank boosted its stake in shares of Danaher by 1.1% in the fourth quarter. Camden National Bank now owns 5,817 shares of the conglomerate’s stock worth $1,292,000 after buying an additional 65 shares during the last quarter. Morgan Stanley boosted its position in Danaher by 0.4% during the second quarter. Morgan Stanley now owns 13,727,018 shares of the conglomerate’s stock worth $3,683,781,000 after purchasing an additional 50,426 shares in the last quarter. Banque Pictet & Cie SA boosted its position in Danaher by 0.6% during the third quarter. Banque Pictet & Cie SA now owns 253,519 shares of the conglomerate’s stock worth $77,181,000 after purchasing an additional 1,441 shares in the last quarter. Pictet & Cie Europe SA raised its holdings in shares of Danaher by 0.4% during the third quarter. Pictet & Cie Europe SA now owns 227,953 shares of the conglomerate’s stock valued at $69,398,000 after acquiring an additional 1,015 shares during the last quarter. Finally, Institutional & Family Asset Management LLC raised its holdings in shares of Danaher by 6.7% during the third quarter. Institutional & Family Asset Management LLC now owns 1,126 shares of the conglomerate’s stock valued at $343,000 after acquiring an additional 71 shares during the last quarter. Institutional investors and hedge funds own 78.42% of the company’s stock.
Several research firms recently commented on DHR. William Blair reaffirmed an “outperform” rating on shares of Danaher in a report on Friday, April 22nd. Barclays cut their price target on Danaher from $355.00 to $325.00 and set an “overweight” rating on the stock in a research note on Thursday, January 27th. Royal Bank of Canada dropped their price target on Danaher from $311.00 to $299.00 and set a “sector perform” rating on the stock in a research report on Friday, April 22nd. Robert W. Baird dropped their price target on Danaher from $334.00 to $319.00 and set an “outperform” rating on the stock in a research report on Friday, April 22nd. Finally, StockNews.com lowered Danaher from a “buy” rating to a “hold” rating in a research note on Friday, April 22nd. Four research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $331.14.
Danaher (NYSE:DHR – Get Rating) last posted its quarterly earnings results on Thursday, April 21st. The conglomerate reported $2.76 earnings per share for the quarter, beating analysts’ consensus estimates of $2.65 by $0.11. Danaher had a net margin of 21.32% and a return on equity of 18.64%. The company had revenue of $7.69 billion for the quarter, compared to the consensus estimate of $7.53 billion. During the same period last year, the company posted $2.52 EPS. The firm’s quarterly revenue was up 11.6% compared to the same quarter last year. As a group, equities research analysts forecast that Danaher Co. will post 10.31 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, July 29th. Shareholders of record on Friday, June 24th will be issued a dividend of $0.25 per share. The ex-dividend date is Thursday, June 23rd. This represents a $1.00 annualized dividend and a yield of 0.40%. Danaher’s payout ratio is 11.57%.
In other news, EVP Joakim Weidemanis sold 6,500 shares of Danaher stock in a transaction on Monday, April 25th. The shares were sold at an average price of $255.74, for a total value of $1,662,310.00. Following the completion of the sale, the executive vice president now owns 86,398 shares in the company, valued at approximately $22,095,424.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 11.20% of the company’s stock.
Danaher Company Profile (Get Rating)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.
- Get a free copy of the StockNews.com research report on Danaher (DHR)
- The Institutions Are Capping Gains In Take-Two Interactive
- Walmart’s “Everyday Low Prices” Gets Burned By Inflation
- VMWare Inc: Strong Revenues and Excellent Potential
- Time to Ride These 3 Mid Cap Momentum Plays
- Beware The Rebound In Home Depot
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.